Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Bafna Pharmaceuticals Annual Report

Bafna Pharmaceuticals Limited has submitted its Annual Report for the financial year 2025-2026 and announced the date for its 31st Annual General Meeting.

Source

BSE filing, NSE: BAFNAPH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bafna Pharmaceuticals Ltd: key numbers

Share price
₹451.60
Market cap
₹1,068 Cr
Revenue (annual)
₹150.6 Cr
Net profit (annual)
₹11.10 Cr
P/E (TTM)
137.2×Sector 46.1×
Promoter holding
75.00%+0.00% QoQ
FII holding
9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bafna Pharmaceuticals Ltd

All →

Other annual report announcements

All →